EXPRESS
membrane, multimeric, toxic and other complex proteins in 48 hours
nPlanta is the high-fidelity, plant-based cell-free system transforming protein expression. Fast, functional, and easy to adopt, it replaces cell-based workflows with a rapid, reliable alternative that scales seamlessly from benchtop to pilot production.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
nPlanta makes the hard targets easy. GPCRs, glycoproteins, VLPs, enzymes — expressed with native folding, disulfide bonds, and PTMs, ready for real-world testing.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
It’s your new foundation for accelerated innovation. As AI speeds the pace of candidate design, nPlanta eliminates the expression bottleneck — delivering functional proteins faster.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
It’s proteins that work, without the wait.
Easily express anything
The fidelity of mammalian expression
with the speed and flexibility of cell-free
Rapid innovation demands proteins that work – not just show up on a gel. Whether you’re producing GPCRs, glycoproteins, exosomes, or VLPs, you need proteins that behave like biology intended: active, reliable, and ready to test.
nPlanta expands and accelerates what’s possible. Our plant-based, cell-free system expresses complex proteins where other platforms fall short, delivering correct tertiary structures, post-translational modification, and native-like activity. Because it mimics eukaryotic biology, your proteins work like they should — and because it’s cell-free, you get results in days, not weeks.
THE nPLANTA ADVANTAGE
FASTER EXPRESSION
Ideal for screening, validation, and early-stage discovery, with expression in 24-48 hours
MORE CAPABLE
Expresses the proteins other platforms can’t: GPCRs, glycoproteins, VLPs, and more
BETTER RESULTS
Higher-order folding & post-translational fidelity means proteins that work, not just express
…AND MORE – CONTACT US WITH QUESTIONS ON YOUR PROJECT
Biology unlocked
Express high-value targets that challenge other systems
GPCRs, cytokines, membrane-bound and glycosylated proteins often misfold or fail in bacterial systems. nPlanta enables rapid, small-scale production in a system that gets eukaryotic folding right the first time
With correct tertiary structure and native-like activity, nPlanta delivers cleaner binding data, better SAR, and fewer false negatives or misleading screens – giving you more confidence in early-stage decisions.
Build more, screen faster, work smarter.
Fewer artifacts. Faster answers. Better data.
FUNCTIONALLY ACTIVE PROTEINS THAT ACCELERATE DISCOVERY
THE nPLANTA SYSTEM
Engineered with purpose-drive genetics and optimized buffers to enable rapid, scalable and cost-effective biomanufacturing of sophisticated biologicals to drive innovation in medicine, agriculture and biotechnology-related fields.
SIMPLE 2-PART SYSTEM
Simply combine base lysate and specialized reaction buffer, add the vector with your gene, incubate for 24-48 hrs and collect your protein
SPECIALIZED BUFFERS
We offer a library of reaction buffers, each optimized for specific expression needs – just combine with our cell-free lysate and add DNA.
OPTIMIZED VECTORS
Choose from specialized vectors for faster reaction speeds, complex eukaryotic proteins, post-translational modifications and other optimizations.
SCALABLE FORMATS
With reaction volumes of 10 µl to liters, accelerate prototyping, screening move right into bioassay validation before industrial scale biomanufacturing.
Integrate with ease
Add the power of a cell-free system
without disruption or delay
You don’t need to add to your infrastructure or overhaul your workflows to unlock the benefits of cell-free protein expression. With nPlanta, it’s simple to integrate high-fidelity, cell-free capabilities into your development process – whether you’re adding early-stage screening capacity, troubleshooting difficult targets, or accelerating design–build–test cycles.